Top Markets
#1 MowCat MowCat +369.00%
#2 龙虾 (Lobster) 龙虾 (Lobster) +66.03%
#3 SODAX SODAX +51.45%
#4 Cortex Cortex +32.57%
#5 DexNet DexNet +23.19%
#6 OpenEden OpenEden +19.26%
#7 BNB Attestation Service BNB Attestation Service +17.78%
#8 MANTRA MANTRA +17.64%
#9 MarsCoin MarsCoin +17.59%
#10 Akedo Akedo +17.05%
Coin of the day
MowCat MowCat
설정
언어
한국어
통화
USD
테마
Chinook Therapeutics, Inc. Chinook Therapeutics, Inc.

Chinook Therapeutics, Inc.

KDNY
주식 순위 #7139
Chinook Therapeutics, Inc., a biotechnology enterprise in the clinical... Chinook Therapeutics, Inc., a biotechnology enterprise in the clinical development phase, is dedicated to the identification, progression, and market introduction of precise medical treatments for kidney-related conditions. The company's primary therapeutic candidate, atrasentan, is an endothelin receptor antagonist currently in Phase III clinical trials. This drug aims to treat IgA nephropathy and various other glomerular diseases characterized by proteinuria. Beyond its lead program, Chinook's investigational pipeline includes BION-1301, an anti-APRIL monoclonal antibody, which is presently being evaluated in a Phase I/II study for IgA nephropathy. Another promising candidate is CHK-336, an oral small molecule designed to inhibit LDHA, intended for patients with primary hyperoxaluria. The firm also maintains active research initiatives exploring solutions for other uncommon and severe chronic kidney ailments. Chinook Therapeutics, Inc. is based in Seattle, Washington.
주가
$40.39
마지막 동기화: 2023-08-18
시가총액
$1.70B
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Chinook Therapeutics, Inc. (KDNY)

카테고리

Healthcare
Chinook Therapeutics, Inc. (KDNY)의 매출
Aug 2026 기준 매출 TTM: 0
Chinook Therapeutics, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 0 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Chinook Therapeutics, Inc.의 수익 기록 (2026 ~ 2026)
매년 말 매출
연도 매출 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH